MedPath

Evaluation of efficacy of topical corticosteroid once daily plus emollient cream once daily vs. topical corticosteroid cream twice daily alone in chronique plaque psoriasis

Conditions
Chronic Plaque psoriasis
Registration Number
NL-OMON25273
Lead Sponsor
Investigator Sponsored TrialProg Giuseppe MicaliClinica DermatologicaUniversity Catania (Italy)
Brief Summary

/A

Detailed Description

Not available

Recruitment & Eligibility

Status
Other
Sex
Not specified
Target Recruitment
30
Inclusion Criteria

Men and women aged 18 years or more
Plaque psoriasis mild to moderate

Exclusion Criteria

Severe plaque psoriasis

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Facial modified Eczema Area Severity Index (EASI) using a 4-scale score (from 0 to 3) (absent, mild, moderate, severe) evaluating: erythema, infiltration, lichenification, erosion
Secondary Outcome Measures
NameTimeMethod
Physician Global assessment (a 6-point scale) from 0 to 5; Tolerability will be evaluated at week 3 and at week 6 using a 4-point score (from 0: very good tolerability to 3: very poor tolerability)
© Copyright 2025. All Rights Reserved by MedPath